Effectiveness of Vedolizumab in Patients With Inflammatory Bowel Disease and Concomitant Primary Sclerosing Cholangitis

被引：0
|
作者：
Santiago, Priscila [1 ]
Robateau, Anthony [1 ]
Lopdrup, Rachel G. [2 ]
Neto, Manuel B. Braga [1 ]
Raffals, Laura [1 ]
Eaton, John [1 ]
Ramos, Guilherme [1 ]
Loftus, Edward V. [3 ]
机构：
[1] Mayo Clin Rochester, Rochester, MN USA
[2] Aurora Hlth Care, Milwaukee, WI USA
[3] Mayo Clin Rochester, Coll Med & Sci, Rochester, MN USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S955
引用
收藏
页码：S688 / S689
页数：2
相关论文
共 50 条
  • [1] INTERNATIONAL EXPERIENCE OF VEDOLIZUMAB IN PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE
    Williamson, Kate D.
    Lytvyak, Ellina
    de Krijger, Manon
    Trivedi, Palak
    Estes, Derek
    Yu, Le
    Pratt, Daniel
    de Vries, Annemarie C.
    Daretti, Luigi
    Liu, Chung Heng
    Bowlus, Christopher L.
    Marschall, Hanns-Ulrich
    Montano-Loza, Aldo J.
    Chapman, Roger W.
    Van der Woude, Christien Janneke
    Marzioni, Marco
    Keshav, Satish
    Ponsioen, Cyriel
    Hirschfield, Gideon
    Levy, Cynthia
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S1097 - S1097
  • [2] Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
    Lynch, Kate D.
    Chapman, Roger W.
    Keshav, Satish
    Montano-Loza, Aldo J.
    Mason, Andrew L.
    Kremer, Andreas E.
    Vetter, Marcel
    de Krijger, Manon
    Ponsioen, Cyriel Y.
    Trivedi, Palak
    Hirschfield, Gideon
    Schramm, Christoph
    Liu, Chung Heng
    Bowlus, Christopher L.
    Estes, Derek J.
    Pratt, Daniel
    Hedin, Charlotte
    Bergquist, Annika
    de Vries, Annemarie C.
    van der Woude, C. Janneke
    Yu, Lei
    Assis, David N.
    Boyer, James
    Ytting, Henriette
    Hallibasic, Emina
    Trauner, Michael
    Marschall, Hanns-Ulrich
    Daretti, Luigi M.
    Marzioni, Marco
    Yimam, Kidist K.
    Perin, Nicola
    Floreani, Annarosa
    Beretta-Piccoli, Benedetta Terziroli
    Rogers, Jennifer K.
    Levy, Cynthia
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (01) : 179 - +
  • [3] Risk of colorectal cancer in patients with primary sclerosing cholangitis and concomitant inflammatory bowel disease compared with primary sclerosing cholangitis only
    Das, Taranika Sarkar
    Ho, Kimberly
    Udaikumar, Jahnavi
    Chen, Bryan
    Delau, Olivia
    Shaukat, Aasma
    Jacobson, Ira
    Sarwar, Raiya
    [J]. HEPATOLOGY RESEARCH, 2024, 54 (09) : 807 - 816
  • [4] CLINICAL AND TRANSLATIONAL OUTCOMES IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE RECEIVING VEDOLIZUMAB
    Williamson, Kate D.
    Slevin, Stephanie
    Willberg, Christian
    Chapman, Roger W.
    Klenerman, Paul
    Keshav, Satish
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S1186 - S1187
  • [5] Clinical and translational outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease receiving vedolizumab
    Williamson, K. D.
    Slevin, S.
    Willberg, C.
    Chapman, R.
    Klenerman, P.
    Keshav, S.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S544 - S545
  • [6] EFFECTIVENESS OF ADALIMUMAB FOR PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
    Franceschet, I.
    Cazzagon, N.
    Floreani, A.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S799 - S799
  • [7] Clinical outcomes and management of patients with concomitant primary sclerosing cholangitis and inflammatory bowel disease
    Wu, K.
    Connell, W.
    Bell, S.
    Kamm, M.
    Wright, E.
    Lust, M.
    Brown, S.
    Thompson, A.
    Ding, N.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 114 - 114
  • [8] EFFECTIVENESS OF ADALIBUMAB FOR PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
    Franceschet, I.
    Cazzagon, N.
    Floreani, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 : E191 - E191
  • [9] EFFECTIVENESS OF ADALIBUMAB FOR PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
    Franceschet, I.
    Cazzagon, N.
    Floreani, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 : E41 - E41
  • [10] Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis
    Hartery, K.
    O'Reilly, S.
    Houlihan, D.
    Doherty, G.
    Mulcahy, H.
    Cullen, G.
    Sheridan, J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (02) : 376 - 378
12345